Pediatric Respiratory Morbidity in Asia: Harnessing Diversity for Better Outcomes

Pediatric respiratory morbidity arises from a wide variety of problems that may be congenital, infective, or allergic in nature, occurring either independently or as part of systemic diseases. These conditions range from simple to complex and life-threatening. Because of this diversity, the burden—both morbidity and mortality—attributable to respiratory diseases in children varies widely not only between countries but also within countries. These variations stem from differences between urban and rural populations, socio-economic disparities, and unequal access to healthcare. The current issue touches upon three different aspects of pediatric respiratory disease in equally diverse settings. Shen et al.[1] have shared their experience in controlling fatal severe asthma among Chinese children. Fatal asthma can result from multiple factors, including individual risk factors affecting disease severity, access to care, quality of care provided, and the availability of appropriate medications and guidance for their use. Interventions to prevent asthma-related mortality in children therefore require a multipronged strategy. The paper discusses and shares experiences in effectively reducing asthma mortality through various health-system-level interventions. It outlines the role of a national action plan focused on asthma control in vulnerable child populations and documents the evolution of national guidance as global and local evidence changed. The authors also highlight the establishment of specialised asthma clinics at different levels of healthcare to support guideline implementation and emphasise the essential role of trained health staff in running these centres. The impact of training on quality of care is brought into focus, along with the long-term sustainability of these efforts through regular certification and plaque-recognition programs. Finally, the paper raises valid concerns regarding the need to identify children at high risk of severe or fatal attacks, proposing alternative strategies since many deaths occur at home or before reaching a health facility. These insights are relevant to other nations and offer a broad framework that can be adapted or adopted to reduce asthma-related mortality in children across diverse settings. Ng et al.’s[2] retrospective study on vitamin D and zinc status among children hospitalised in Hong Kong SAR documents deficiencies in these micronutrients, which play important roles in preventing respiratory diseases. Only 24% of children showed adequate levels of both nutrients, while about 25.6% had combined deficiency or insufficiency. Such local data is important as the global prevalence of low vitamin D varies according to latitude, skin pigmentation, sun exposure, cultural practices, and diet. Many LMIC populations have a high prevalence of low 25(OH)D levels in infants and adolescents. Zinc deficiency is similarly common in low-resource settings where diets are cereal-based, animal-protein intake is low, and diarrhoeal disease burden is high. Soil zinc depletion and food-processing techniques further reduce dietary zinc bioavailability. High-risk groups for these deficiencies include exclusively breastfed infants without supplementation, preterm infants, children with malabsorption (such as cystic fibrosis, celiac disease, or inflammatory bowel disease), those with chronic liver or renal disease, children with limited sunlight exposure, obese children (due to vitamin D sequestration), and children with recurrent infections. Serum 25-hydroxyvitamin D [25(OH)D] is the accepted marker of vitamin D status; however, acute illness and inflammation can alter circulating levels. Variability in vitamin D–binding protein levels and assay methods also influences interpretation. Similarly, serum/plasma zinc has high biological variability and is reduced by inflammation, fasting status, and time of day. These factors must be considered when interpreting these results. Large, methodologically robust meta-analyses and individual participant data (IPD) analyses exist for both nutrients, although results vary depending on outcome measured, population characteristics, dosing regimen, and baseline status. Numerous randomized controlled trials have evaluated vitamin D supplementation for preventing acute respiratory infections (ARIs). Earlier pooled analyses showed modest reductions in ARI risk, particularly among individuals who were vitamin D-deficient at baseline and when supplements were administered daily or weekly rather than as large bolus doses.[3] More recent and larger meta-analyses—including IPD analyses—report more nuanced or null overall effects when newer trials are included.[4,5] Evidence for benefit in reducing asthma exacerbations exists in some trials but is not consistently reproduced across all studies.[6] Factors contributing to these mixed results include heterogeneity in baseline vitamin D status, differences in dosing regimens, age distributions, and outcome definitions. For zinc, evidence of benefit in conditions other than acute diarrhoea is mixed. Some trials and meta-analyses show shorter hospital stays or faster clinical recovery with zinc supplementation, especially in populations with prevalent baseline deficiency; however, other analyses report no consistent benefit across all settings.[7-9] Trials combining zinc with vitamin A or other micronutrients have also produced mixed findings; synergistic effects are biologically plausible but not consistently demonstrated. Targeted supplementation—treating documented deficiency—shows more consistent benefit than routine high-dose supplementation in unselected populations. For pneumonia and other severe respiratory diseases, the evidence for vitamin D or zinc as adjunct therapies is mixed and appears to depend on baseline nutritional status, age, geography, and dosing schedules. The study by Ng et al.[2] adds to understanding of deficiency prevalence in the Hong Kong SAR population. Huang et al.[10] have shared their experience with flexible fiberoptic pediatric bronchoscopy (FFB) based on a chart review of 155 children from a centre in southern Taiwan. The article highlights the indications and utility of the procedure across different age groups. They document the role of FFB in evaluating airway abnormalities in infants presenting with noisy breathing, and their findings align with many other published studies. However, variations in diagnostic yield across studies do exist, partly because upper airway disease and stridor may be primarily evaluated by ENT specialists in some centres. Hope this diverse mix of the articles in this issue have something for our equally diverse readership. May you ring in the New Year with Happy reading! Financial support and sponsorship Nil. Conflicts of interest There are no conflicts of interest.